Therapeutic Options To Prevent Severe COVID-19 in Immunocompromised People

Resource: Therapeutic Options To Prevent Severe COVID-19 in Immunocompromised People

During this webinar, presenters discuss the Food and Drug Administration's (FDA) role in issuing Emergency Use Authorizations (EUAs) for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.

Source: CDC
Topic(s): Infection Control & Prevention; Patient-Centered Care
Audience(s): Clinicians, Clinical Leaders
Format: Video
Length of Video: 1 hour
Publication Date: August 12, 2021